Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Trichoscopy is essential for diagnosing and treating autoimmune cicatricial alopecia early.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Different rheumatological diseases can cause specific skin problems.

Combination therapies might work better for some vitiligo patients, but results vary.

Early diagnosis and thorough evaluation are crucial for better outcomes in alopecic sarcoidosis.

Melatonin in a special emulsion can help treat hair loss more effectively.

Lifestyle choices like stress, smoking, heavy drinking, sun exposure, and chemical hair treatments might speed up hair loss in people with androgenetic alopecia.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Red light exposure can slow aging in mice by improving fat metabolism.

Hair shaft disorders often indicate genetic or systemic issues and are managed by minimizing damage.

The model and estimator can predict drug exposure in kidney transplant patients well.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

UV exposure reduced hair shine in mice, but minoxidil helped restore it.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Air pollution can damage hair and scalp, causing hair loss and inflammation.

Centella asiatica extract taken orally can reduce skin aging from UVB exposure.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.